Clinical Trial

Fluid Administration in Ketoacidosis (DRINK)

Study acronym: DRINK
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Management of severe diabetic ketoacidosis is based on insulin therapy, correction of metabolic disorders and fluid resuscitation. Current recommendations recommend the first-line use of isotonic saline, whose composition is unbalanced, rich in chloride and sodium compared with plasma. Administration of large volumes of isotonic saline is associated with a risk of hyperchloremic metabolic acidosis and acute renal failure. Balanced solutions (e.g. Ringer Lactate) are solutions with a more balanced electrolyte composition close to that of plasma. They could therefore enable diabetic ketoacidosis to be resolved more quickly than isotonic saline, due to a lower risk of hyperchloremic acidosis. Preliminary data suggest a potential benefit of balanced solutions for fluid resuscitation of patients with severe diabetic ketoacidosis in terms of resolution of diabetic ketoacidosis, but no randomized controlled double-blind study to date has compared balanced solution vs. isotonic saline in this context.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-02.
Status change: Not Yet Recruiting → Recruiting 2026-05-21
Trial Details
NCT Number NCT06541535
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Diabetic Keto-acidosis
Enrollment 300 participants
Start Date 2025-11-26
Primary Completion 2027-12 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-26